• Mon. Oct 19th, 2026

Denosumab Preferred Over Alendronate for BMD Protection

Byindianadmin

Nov 14, 2020

“Glucocorticoids remain the mainstay of treatment of rheumatic diseases, but [they are] a major danger element for osteoporosis and fracture.” Medscape Medical News
Read More

Click to listen highlighted text!